The purpose of this legislation, known as the "Epinephrine's Pharma Inflated Price Ends Now Act" or the "EPIPEN Act," is to make epinephrine delivery systems more affordable for individuals who need them. This is particularly important for people at risk of severe allergic reactions, as these delivery systems, such as auto-injectors, are essential for their safety. The key provisions of the act require that health insurance plans, including both group and individual coverage, must cover epinephrine delivery systems without applying any deductibles.